| 0 | ℹ |
Synthetic transcription factors designed by domain recombination enhance CAR T cell antitumor function.
(linkinghub.elsevier.com)
|
Cell 2026-08-19 | #immunotherapy #car-t #protein design #transcriptomics #epigenetics | |
| 0 | ℹ |
A phase 1 feasibility trial of BE-CAR33, an "off-the-shelf" base-edited CAR33 T cell therapy for acute myeloid leukemia.
(science.org)
|
Science Translational Medicine 2026-08-19 | #immunotherapy #car-t #leukemia #base-editing #transplantation |